Non-Hodgkins Lymphoma: Review of Conventional Treatments
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
279-291
Author(s):
P. Multani, C.A. White and A. Grillo-Lopez
Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
301-311
Author(s):
A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White
Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
341-349
Author(s):
C. Krasner and R.M. Joyce
Helicase Domain Containing Proteins in Human Disorders
Journal:
Current Genomics
Volume:
2
Page:
305-324
Author(s):
Adayabalam S. Balajee and Colette ApRhys
Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale Analysis of Rodent Cancer Models
Journal:
Current Genomics
Volume:
2
Page:
325-335
Author(s):
R. Kappler and H. Scherthan
Turner Syndrome : How Is It Made Up?
Journal:
Current Genomics
Volume:
2
Page:
357-377
Author(s):
Tsutomu Ogata
Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Journal:
Current Genomics
Volume:
2
Page:
399-415
Author(s):
Tuan Vo-Dinh and Minoo Askari
Oxytosis: A Novel Form of Programmed Cell Death
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
497-506
Author(s):
Shirlee Tan, David Schubert and Pamela Maher
The Nature of Enzymes Involved in Uracil-DNA Repair: Isoform Charac-teristics of Proteins Responsible for Nuclear and Mitochondrial Genomic Integrity 1
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
335-347
Author(s):
Sal Caradonna and Susan Muller-weeks
dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
349-360
Author(s):
Friedrich A. Grasser, Bernd F.M. Romeike, Gerald Niedobitek, John Nicholls and Elisabeth Kremmer